Biomarkers for identifying high-grade glioma subjects responsive to anti-angiogenic drug

摘要

The present invention relates to a Sox7 and Sox17 biomarker for the determination of a highly malignant brain tumor subject for administration of a VEGF pathway antagonist. It is possible to determine whether administration of a VEGF pathway antagonist to a highly malignant brain tumor subject is effective by using the biomarker of the present invention It is possible to judge.